Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tian Jing Formula is a Traditional Chinese Medicine (TCM) herbal formulation developed by Longhua Hospital at the Shanghai University of Traditional Chinese Medicine. It is specifically designed to treat premature ovarian insufficiency (POI) characterized by kidney deficiency, following the therapeutic principle of capitalizing the kidney and regulating the liver. The formula is intended to improve ovarian reserve function, enhance ovarian responsiveness to stimulation, and mitigate symptoms resulting from low estrogen levels. It is currently undergoing multicenter clinical evaluation to validate its efficacy and safety profile in restoring reproductive endocrine function in patients with POI.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Tian Jing Formula.